Literature DB >> 21352469

Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients.

M J Hollestelle1, C M Loots, A Squizzato, T Renné, B J Bouma, P G de Groot, P J Lenting, J C M Meijers, V E A Gerdes.   

Abstract

BACKGROUND: Aortic stenosis patients often show bleeding complications. Previously, a prolonged platelet function analyzer (PFA-100) closure time was observed with plasma of severe aortic stenosis patients. To elucidate a possible role of circulating preactivated von Willebrand factor (VWF), we determined the level of VWF in its active, platelet-binding conformation in plasma of patients with aortic stenosis. PATIENTS/
METHODS: Sixty-two aortic stenosis patients were included in this study. VWF and related parameters were measured, and the results were related to severity of aortic stenosis.
RESULTS: VWF activation factor, indicating the proportion of circulating VWF able to bind to platelets, correlated negatively with peak transvalvular gradient and PFA-100 closure time. No correlation was observed between ADAMTS13 activity and peak transvalvular gradient or PFA-100 closure time. Both VWF antigen and VWF propeptide levels were significantly higher in patients with mild and moderate aortic stenosis, but not in those with severe stenosis.
CONCLUSIONS: Our data demonstrate that the aortic pressure gradient is inversely associated with VWF activation factor, but not with VWF antigen or VWF multimerization in patients with aortic stenosis. These findings might have implications for the bleeding observed in patients with aortic stenosis.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352469     DOI: 10.1111/j.1538-7836.2011.04247.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  6 in total

1.  Turbulent Intensity of Blood Flow in the Healthy Aorta Increases With Dobutamine Stress and is Related to Cardiac Output.

Authors:  Jonathan Sundin; Mariana Bustamante; Tino Ebbers; Petter Dyverfeldt; Carl-Johan Carlhäll
Journal:  Front Physiol       Date:  2022-05-25       Impact factor: 4.755

2.  Non-dimensional analysis of retinal microaneurysms: critical threshold for treatment.

Authors:  Elishai Ezra; Eliezer Keinan; Yossi Mandel; Michael E Boulton; Yaakov Nahmias
Journal:  Integr Biol (Camb)       Date:  2013-03       Impact factor: 2.192

3.  von Willebrand factor propeptide: biology and clinical utility.

Authors:  Sandra L Haberichter
Journal:  Blood       Date:  2015-07-27       Impact factor: 22.113

Review 4.  Transport physics and biorheology in the setting of hemostasis and thrombosis.

Authors:  L F Brass; S L Diamond
Journal:  J Thromb Haemost       Date:  2016-03-30       Impact factor: 5.824

5.  Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor.

Authors:  Lisa N van der Vorm; Li Li; Dana Huskens; Walid Chayouâ; Hilde Kelchtermans; Philip G de Groot; Mark Roest; Jasper A Remijn; Bas de Laat
Journal:  PLoS One       Date:  2019-02-13       Impact factor: 3.240

6.  Assessment of exercise-induced changes in von Willebrand factor as a marker of severity of aortic stenosis.

Authors:  Jo M Zelis; Frederik M Zimmermann; Froukje P J Andriessen; Patrick Houthuizen; Jop Van de Ven; Jolanda Leuverman; Nils P Johnson; Nico H J Pijls; Volkher Scharnhorst; Marcel Van 't Veer; Pim A L Tonino
Journal:  Open Heart       Date:  2020-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.